IFN-γ-induced upregulation of Fcγ-receptor-I during activation of monocytic cells requires the PKR and NFκB pathways

Molecular Immunology

Volumn 44, Issue 4, 2007, Pages 615-624

  Kårehed, Karin ^a   Dimberg, Anna ^a   Dahl, Staffan ^a   Nilsson, Kenneth ^a   Öberg, Fredrik ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Fc receptor; Immune response; Inflammation; Interferon; NF B; PKR; Signal transduction; Stat1; Transcription; U 937; U937

Indexed keywords

2 AMINOPURINE; CD64 ANTIGEN; DOUBLE STRANDED RNA; FC RECEPTOR; GAMMA INTERFERON; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; PROTEIN KINASE R; SERINE; SMALL INTERFERING RNA; STAT1 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

CELL LINE; EIF-2 KINASE; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; IMIDAZOLES; INTERFERON-GAMMA, RECOMBINANT; MACROPHAGE ACTIVATION; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; QUINOXALINES; RECEPTORS, IGG; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 33747822627     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.01.013     Document Type: Article

References (52)

1. Aittomaki S., Yang J., Scott E.W., Simon M.C., and Silvennoinen O. Distinct functions for signal transducer and activator of transcription 1 and PU. 1 in transcriptional activation of Fc gamma receptor I promoter. Blood 100 (2002) 1078-1080
2. Aittomaki S., Yang J., Scott E.W., Simon M.C., and Silvennoinen O. Molecular basis of Stat1 and PU. 1 cooperation in cytokine-induced Fcgamma receptor I promoter activation. Int. Immunol. 16 (2004) 265-274
3. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499
4. Bonnet M.C., Weil R., Dam E., Hovanessian A.G., and Meurs E.F. PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol. Cell Biol. 20 (2000) 4532-4542
5. Burke J.R., Pattoli M.A., Gregor K.R., Brassil P.J., MacMaster J.F., McIntyre K.W., Yang X., Iotzova V.S., Clarke W., Strnad J., Qiu Y., and Zusi F.C. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J. Biol. Chem. 278 (2003) 1450-1456
6. Cheshire J.L., and Baldwin Jr. A.S. Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation. Mol. Cell Biol. 17 (1997) 6746-6754
7. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
8. Clemens M.J. Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23 (2004) 3180-3188
9. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
10. Deb A., Haque S.J., Mogensen T., Silverman R.H., and Williams B.R. RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J. Immunol. 166 (2001) 6170-6180
11. Decker T., and Kovarik P. Serine phosphorylation of STATs. Oncogene 19 (2000) 2628-2637
12. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15623-15628
13. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., and Karin M. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell Biol. 16 (1996) 1295-1304
14. Dimberg A., Karlberg I., Nilsson K., and Oberg F. Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells. Blood 102 (2003) 254-261
15. Dimberg A., Nilsson K., and Oberg F. Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. Blood 96 (2000) 2870-2878
16. Donze O., and Picard D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res. 30 10 (2002) e46
17. Durbin J.E., Hackenmiller R., Simon M.C., and Levy D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84 (1996) 443-450
18. Eichbaum Q.G., Iyer R., Raveh D.P., Mathieu C., and Ezekowitz R.A. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU. 1 site and a transcription initiator consensus. J. Exp. Med. 179 (1994) 1985-1996
19. Gil J., Garcia M.A., Gomez-Puertas P., Guerra S., Rullas J., Nakano H., Alcami J., and Esteban M. TRAF family proteins link PKR with NF-kappa B activation. Mol. Cell Biol. 24 (2004) 4502-4512
20. Gil M.P., Bohn E., O'Guin A.K., Ramana C.V., Levine B., Stark G.R., Virgin H.W., and Schreiber R.D. Biologic consequences of Stat1-independent IFN signalling. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6680-6685
21. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3 (2003) 23-35
22. Gusella G.L., Musso T., Rottschafer S.E., Pulkki K., and Varesio L. Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma. J. Immunol. 154 (1995) 345-354
23. Guyre P.M., Morganelli P.M., and Miller R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest. 72 (1983) 393-397
24. Horng T., Barton G.M., and Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2 (2001) 835-841
25. Ioan-Facsinay A., de Kimpe S.J., Hellwig S.M., van Lent P.L., Hofhuis F.M., van Ojik H.H., Sedlik C., da Silveira S.A., Gerber J., de Jong Y.F., Roozendaal R., Aarden L.A., van den Berg W.B., Saito T., Mosser D., Amigorena S., Izui S., van Ommen G.J., van Vugt M., van de Winkel J.G., and Verbeek J.S. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16 (2002) 391-402
26. Ishii T., Kwon H., Hiscott J., Mosialos G., and Koromilas A.E. Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene 20 (2001) 1900-1912
27. Jiang Z., Johnson H.J., Nie H., Qin J., Bird T.A., and Li X. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J. Biol. Chem. 278 (2003) 10952-10956
28. Kovarik P., Mangold M., Ramsauer K., Heidari H., Steinborn R., Zotter A., Levy D.E., Muller M., and Decker T. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20 (2001) 91-100
29. Kumar A., Yang Y.L., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissmann C., and Williams B.R. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16 (1997) 406-416
30. Larsson L.-G., Ivhed R., Öberg F., Pettersson U., and Nilsson K. c-jun is induced to high continuous expression during differentiation of hematopoietic cells and is regulated independently from c-fos. Leuk. Lymphoma 4 (1991) 193-204
31. Maggi Jr. L.B., Heitmeier M.R., Scheuner D., Kaufman R.J., Buller R.M., and Corbett J.A. Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J. 19 (2000) 3630-3638
32. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell Jr. J.E., Stark G.R., and Kerr I.M. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12 (1993) 4221-4228
33. Nathan C.F., Murray H.W., Wiebe M.E., and Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158 (1983) 670-689
34. Olson M.C., Scott E.W., Hack A.A., Su G.H., Tenen D.G., Singh H., and Simon M.C. PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3 (1995) 703-714
35. Osada S., Takano K., Nishihara T., Suzuki T., Muramatsu M., and Imagawa M. CCAAT/enhancer-binding proteins alpha and beta interact with the silencer element in the promoter of glutathione S-transferase P gene during hepatocarcinogenesis. J. Biol. Chem. 270 (1995) 31288-31293
36. Pearse R.N., Feinman R., and Ravetch J.V. Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by gamma-interferon is mediated through common DNA response elements. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 11305-11309
37. Pearse R.N., Feinman R., Shuai K., Darnell Jr. J.E., and Ravetch J.V. Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4314-4318
38. Perez C., Coeffier E., Moreau-Gachelin F., Wietzerbin J., and Benech P.D. Involvement of the transcription factor PU. 1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor. Mol. Cell Biol. 14 (1994) 5023-5031
39. Perez C., Wietzerbin J., and Benech P.D. Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism. Mol. Cell Biol. 13 (1993) 2182-2192
40. Pine R. Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element. Nucleic Acids Res. 25 (1997) 4346-4354
41. Ramana C.V., Gil M.P., Han Y., Ransohoff R.M., Schreiber R.D., and Stark G.R. Stat1-independent regulation of gene expression in response to IFN-gamma. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6674-6679
42. Ramana C.V., Grammatikakis N., Chernov M., Nguyen H., Goh K.C., Williams B.R., and Stark G.R. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J. 19 (2000) 263-272
43. Roy S.K., Wachira S.J., Weihua X., Hu J., and Kalvakolanu D.V. CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J. Biol. Chem. 275 (2000) 12626-12632
44. Sizemore N., Agarwal A., Das K., Lerner N., Sulak M., Rani S., Ransohoff R., Shultz D., and Stark G.R. Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes. Proc Natl. Acad. Sci. U.S.A. 101 (2004) 7994-7998
45. Tam N.W., Ishii T., Li S., Wong A.H., Cuddihy A.R., and Koromilas A.E. Upregulation of STAT1 protein in cells lacking or expressing mutants of the double-stranded RNA-dependent protein kinase PKR. Eur. J. Biochem. 262 (1999) 149-154
46. Tanaka H., and Samuel C.E. Mouse interferon-inducible RNA-dependent protein kinase Pkr gene: cloning and sequence of the 5′-flanking region and functional identification of the minimal inducible promoter. Gene 246 (2000) 373-382
47. Varinou L., Ramsauer K., Karaghiosoff M., Kolbe T., Pfeffer K., Muller M., and Decker T. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity 19 (2003) 793-802
48. Wen Z., Zhong Z., and Darnell Jr. J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
49. Williams B.R., 2001. Signal integration via PKR. Sci STKE 2001, RE2.
50. Wong A.H., Durbin J.E., Li S., Dever T.E., Decker T., and Koromilas A.E. Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J. Biol. Chem. 276 (2001) 13727-13737
51. Wong A.H., Tam N.W., Yang Y.L., Cuddihy A.R., Li S., Kirchhoff S., Hauser H., Decker T., and Koromilas A.E. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16 (1997) 1291-1304
52. Zinn K., Keller A., Whittemore L.A., and Maniatis T. 2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science 240 (1988) 210-213